Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escholzia Tablets for Insomnia (Adults)
2023-508169-34-00Phase 3Withdrawn
- Sponsor
- A.Vogel
- Start
- Nov 2023
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of AV-EC2023 in Insomnia (3 arms), sponsored by A.Vogel. Primary endpoints: Change in perceived sleep quality (Phase A) and Safety and tolerability (Phase B). Planned start Nov 2023; status: withdrawn.
02
Drugs
AV-EC2023
03
Conditions
Insomnia
Beyond the preview
Go deeper on 2023-508169-34-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-508169-34-00.